GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 137 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q3 2017. The put-call ratio across all filers is 0.35 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $4,086,000 | +231.7% | 60,000 | +100.0% | 0.04% | +125.0% |
| Q4 2018 | $1,232,000 | -53.7% | 30,000 | -57.1% | 0.02% | -51.5% |
| Q3 2018 | $2,660,000 | -61.9% | 70,000 | -68.9% | 0.03% | -81.0% |
| Q3 2017 | $6,986,000 | +155.4% | 225,000 | +125.0% | 0.17% | +216.4% |
| Q2 2017 | $2,735,000 | – | 100,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 850,000 | $46,869,000 | 6.00% |
| Asymmetry Capital Management, L.P. | 155,232 | $8,559,000 | 5.50% |
| Grace Capital | 124,749 | $6,878,000 | 5.33% |
| Fernwood Investment Management, LLC | 187,477 | $10,337,000 | 4.88% |
| Perceptive Advisors | 5,800,996 | $319,867,000 | 4.67% |
| ArchPoint Investors | 217,510 | $11,993,000 | 3.83% |
| GREAT POINT PARTNERS LLC | 655,676 | $36,154,000 | 3.25% |
| Profit Investment Management, LLC | 42,196 | $2,328,000 | 1.44% |
| Bain Capital Public Equity Management II, LLC | 381,868 | $21,056,000 | 1.39% |
| Taylor Wealth Management Partners | 52,597 | $2,900,000 | 1.33% |